An update of anti-viral treatment of COVID-19
COVID-19의 항바이러스 치료 업데이트
Review
[키워드] ACE-2
Administered
Anti-viral treatment
Antiviral
AT-527
biological processe
biological processes
bromhexine
camostat
clinical trial
clinical trials
convalescent plasma
COVID-19
drug
dutasteride
early phase
effective
effective antiviral treatment
evaluated
Favipiravir
fluvoxamine
group
Host
host protein
host proteins
human cell
Hydroxychloroquine
include
inhibitor
inhibitors
interfere
interferons
Ivermectin
knowledge
Laboratory
lactoferrin
Lopinavir
Lopinavir/ritonavir
merimepodib
molnupiravir
moment
monoclonal antibodies
monoclonal antibody
nanobodies
natural immunity
niclosamide
nitazoxanide
pandemic
PF-07304814
PF-07321332
Plitidepsin
protease
Protein
Proteins
proxalutamide
PTC299
RCTs
Remdesivir
Result
Ritonavir
RNA
SARS-CoV-2
subject
Support
target protein
target proteins
the disease
to define
Treatment
treatment for COVID-19
treatment of COVID-19
Trial
umifenovir
Viral
viral entry
Viral RNA
virus
[DOI] 10.3906/sag-2106-250 PMC 바로가기 [Article Type] Review
[DOI] 10.3906/sag-2106-250 PMC 바로가기 [Article Type] Review